2009
DOI: 10.1080/00036840802600475
|View full text |Cite
|
Sign up to set email alerts
|

An implicit price of a DALY for use in a cost-benefit analysis of ARVs

Abstract: This article uses the revealed preference approach to estimate the price for a Disability Adjusted Life Year (DALY) implied by grant decisions by the Global Fund for AIDS, tuberculosis (TB) and malaria (GFATM). A cost-benefit criterion is used that requires the DALY price exceed the cost-effectiveness ratio. The estimated price was $6300 for a DALY saved from any disease, but it was $11 900 from a DALY saved specifically from HIV/AIDS. Estimates of the cost-effectiveness ratios of Antiretroviral Drug Therapies… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
24
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 22 publications
(25 citation statements)
references
References 14 publications
1
24
0
Order By: Relevance
“…In order to express program benefits in the same units as costs, the number of DALYs gained from each program was multiplied by a marginal value of $7,773, before subtracting the total cost of the program to obtain net benefits (which are presented in per capita terms in the results). The figure for the marginal value per DALY saved is obtained from the cost‐effectiveness threshold of three times per GDP per capita recommended by the WHO‐CHOICE project, and also happens to be within the range of marginal values reported in a revealed preference study estimating the value of a quality‐adjusted life year in terms of international global health funding for malaria, tuberculosis, and HIV …”
Section: Methodssupporting
confidence: 60%
See 2 more Smart Citations
“…In order to express program benefits in the same units as costs, the number of DALYs gained from each program was multiplied by a marginal value of $7,773, before subtracting the total cost of the program to obtain net benefits (which are presented in per capita terms in the results). The figure for the marginal value per DALY saved is obtained from the cost‐effectiveness threshold of three times per GDP per capita recommended by the WHO‐CHOICE project, and also happens to be within the range of marginal values reported in a revealed preference study estimating the value of a quality‐adjusted life year in terms of international global health funding for malaria, tuberculosis, and HIV …”
Section: Methodssupporting
confidence: 60%
“…The calculated impacts include metrics related to malaria burden (e.g., incidence of uncomplicated cases, severe cases, and deaths, which are aggregated into disability‐adjusted life years or DALYs) and program costs. We employ a benefit‐cost metric in which health impacts are computed in terms of disability‐adjusted life years (DALYs) and then monetized using cost‐effectiveness thresholds, in order to compare with program costs . Below we describe the components of the model directly relevant for the analysis in this article, and refer readers to the MDAST user manual and the open‐source model for further details and references…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…60 The results can be used to estimate the number of DALYs potentially saved through management of introduced mammal populations on a particular island, and then be assigned a monetary value to be compared with the monetary costs of the management action. 61 Management of introduced mammals on inhabited islands implies social, cultural, and economic challenges that should be considered when assessing the feasibility of management actions. 58,62,63 For example, costs of eradication vary greatly, mostly as a function of population size, island area (e.g., US $3 to $20,000 per hectare), the type of eradication method (target species dependent), and other variable costs such as capacity building, environmental compliance, and mitigation of nontarget species.…”
Section: Discussionmentioning
confidence: 99%
“…60 The monetary value of DALYs can be estimated based on the region's income, the funds allocated toward disease alleviation, and the DALY value of the disease. 61 The fitted models above could be used to provide an initial estimate of disease incidence or seroprevalence on islands, island countries, or countries within islands where this information is missing to identify prospective islands in which local data should be collected. Ultimately, these results could be converted into DALYs.…”
Section: Discussionmentioning
confidence: 99%